X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
bisphosphonate-related osteonecrosis (441) 441
index medicus (344) 344
dentistry, oral surgery & medicine (318) 318
humans (315) 315
dentistry (294) 294
necrosis (221) 221
bones (217) 217
female (204) 204
osteonecrosis (195) 195
surgery (186) 186
male (185) 185
risk-factors (179) 179
zoledronic acid (178) 178
jaw (160) 160
aged (138) 138
bisphosphonates (138) 138
osteoporosis (132) 132
bone density conservation agents - adverse effects (130) 130
middle aged (125) 125
bisphosphonate-related osteonecrosis of the jaw (120) 120
diphosphonates - adverse effects (112) 112
cancer (106) 106
therapy (105) 105
animals (98) 98
cancer-patients (92) 92
bisphosphonate (88) 88
bone (88) 88
denosumab (86) 86
management (85) 85
prevention (83) 83
surgeons position paper (82) 82
risk factors (81) 81
american association (80) 80
analysis (80) 80
tooth extraction (68) 68
osteonecrosis of the jaw (67) 67
aged, 80 and over (65) 65
alendronate (65) 65
osteonecrosis - chemically induced (61) 61
rats (60) 60
health aspects (58) 58
multiple-myeloma (58) 58
bisphosphonate-associated osteonecrosis of the jaw - etiology (56) 56
care and treatment (55) 55
diphosphonates - administration & dosage (55) 55
bone density conservation agents - administration & dosage (54) 54
adult (53) 53
phosphonates (53) 53
retrospective studies (51) 51
bisphosphonate-associated osteonecrosis of the jaw - surgery (50) 50
treatment outcome (49) 49
imidazoles - adverse effects (47) 47
bisphosphonate-associated osteonecrosis of the jaw - pathology (46) 46
bone density conservation agents - therapeutic use (46) 46
bronj (46) 46
endocrinology & metabolism (46) 46
oncology (45) 45
jaws (42) 42
medication-related osteonecrosis (42) 42
abridged index medicus (41) 41
bisphosphonate-associated osteonecrosis of the jaw - diagnosis (41) 41
bisphosphonate-associated osteonecrosis of the jaw - therapy (40) 40
jaw diseases - chemically induced (40) 40
diphosphonates - therapeutic use (39) 39
osteoporosis - drug therapy (39) 39
mronj (38) 38
patients (38) 38
bisphosphonate-associated osteonecrosis of the jaw - diagnostic imaging (37) 37
medical research (37) 37
research (37) 37
in-vitro (36) 36
article (35) 35
association (35) 35
bone metastases (35) 35
diphosphonates - pharmacology (35) 35
imidazoles - administration & dosage (35) 35
medicine & public health (35) 35
pamidronate (35) 35
medicine, research & experimental (34) 34
wound healing (34) 34
drugs (33) 33
bisphosphonate-related osteonecrosis of the jaws (32) 32
disease models, animal (32) 32
medication-related osteonecrosis of the jaw (32) 32
medicine, experimental (32) 32
metastasis (32) 32
oral bisphosphonates (32) 32
bone density conservation agents - pharmacology (31) 31
diphosphonates (31) 31
postmenopausal women (31) 31
diagnosis (30) 30
mechanisms (30) 30
mice (30) 30
time factors (30) 30
biocompatibility (28) 28
follow-up studies (28) 28
orthopedics (28) 28
breast-cancer (27) 27
disease (27) 27
dental implants (26) 26
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (597) 597
Japanese (15) 15
Spanish (6) 6
German (5) 5
Korean (5) 5
French (3) 3
Hungarian (3) 3
Italian (3) 3
Portuguese (2) 2
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Oral and Maxillofacial Surgery, ISSN 0278-2391, 2014, Volume 72, Issue 10, pp. 1938 - 1956
Journal Article
Expert Opinion on Drug Safety, ISSN 1474-0338, 07/2016, Volume 15, Issue 7, pp. 925 - 935
Journal Article
Journal Article
Journal of Oral and Maxillofacial Surgery, ISSN 0278-2391, 2017, Volume 75, Issue 10, pp. 2154 - 2161
Journal Article
Journal Article
Journal of Cranio-Maxillo-Facial Surgery, ISSN 1010-5182, 05/2018, Volume 46, Issue 5, pp. 815 - 824
Journal Article
Journal Article
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 02/2011, Volume 103, Issue 3, pp. 232 - 240
Nitrogen-containing bisphosphonates have been associated with the development of osteonecrosis of the jaws (ONJ), but the lack of reliable epidemiological data... 
MULTIPLE-MYELOMA | ZOLEDRONIC ACID | IN-VITRO | RISK-FACTORS | ONCOLOGY | BEAGLE DOGS | NITROGEN-CONTAINING BISPHOSPHONATES | BISPHOSPHONATE-RELATED OSTEONECROSIS | BONE | PREVALENCE | AUTOSOMAL-DOMINANT OSTEOPETROSIS | Jaw Diseases - diagnosis | Osteonecrosis - epidemiology | Humans | Jaw Diseases - prevention & control | Osteomyelitis - chemically induced | Antibodies, Monoclonal - adverse effects | Tomography, X-Ray Computed | Positron-Emission Tomography | Antineoplastic Agents - administration & dosage | Osteonecrosis - metabolism | Jaw Diseases - metabolism | Jaw Diseases - chemically induced | Mouth Mucosa - drug effects | RANK Ligand - immunology | Antibodies, Monoclonal, Humanized | Antineoplastic Agents - adverse effects | Etidronic Acid - adverse effects | Pyrroles - adverse effects | Vitamin D - administration & dosage | Risedronate Sodium | Diphosphonates - adverse effects | Etidronic Acid - analogs & derivatives | RANK Ligand - adverse effects | Osteonecrosis - diagnosis | Radiography, Panoramic | Osteonecrosis - etiology | Bone Density Conservation Agents - adverse effects | Macrophages - pathology | Imidazoles - adverse effects | Jaw Diseases - etiology | Risk Factors | Diphosphonates - administration & dosage | Denosumab | Jaw Diseases - epidemiology | Mevalonic Acid - metabolism | Monocytes - drug effects | Magnetic Resonance Imaging | Alendronate - adverse effects | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Indoles - adverse effects | Signal Transduction - drug effects | Macrophages - drug effects | Osteonecrosis - chemically induced | Osteonecrosis - prevention & control | Diphosphonates - pharmacology | Osteoclasts - drug effects | Complications and side effects | Diphosphonates | Physiological aspects | Bones | Research | Macrophages | Risk factors | Necrosis
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 09/2015, Volume 30, Issue 9, pp. 1627 - 1640
ABSTRACT Osteonecrosis of the jaws (ONJ) is a significant complication of antiresorptive medications, such as bisphosphonates and denosumab. Antiresorptive... 
ZOLEDRONIC ACID | ALVEOLAR BONE | BISPHOSPHONATES | OSTEOCLASTS | DENOSUMAB | OSTEONECROSIS OF THE JAW (ONJ) | ANTIRESORPTIVES | alveolar bone | antiresorptives | zoledronic acid | osteoclasts | bisphosphonates | denosumab | osteonecrosis of the jaw (ONJ) | RISK-FACTORS | INDUCE OSTEONECROSIS | NITROGEN-CONTAINING BISPHOSPHONATES | BONE-RESORPTION | POSTMENOPAUSAL OSTEOPOROSIS | CANCER-PATIENTS | CLINICAL-APPLICATIONS | BISPHOSPHONATE-RELATED OSTEONECROSIS | ENDOCRINOLOGY & METABOLISM | EXPERIMENTAL PERIODONTITIS | KAPPA-B LIGAND | RANK Ligand - metabolism | Recombinant Fusion Proteins - pharmacology | Tartrate-Resistant Acid Phosphatase | Male | Mandible - diagnostic imaging | X-Ray Microtomography | Acid Phosphatase - metabolism | Isoenzymes - metabolism | Diphosphonates - therapeutic use | Disease Models, Animal | Bone Resorption | Maxilla - diagnostic imaging | Mice, Inbred C57BL | Osteoprotegerin - pharmacology | Abscess | Rats | Imidazoles - pharmacology | Osteoclasts - metabolism | Animals | RANK Ligand - antagonists & inhibitors | Bisphosphonate-Associated Osteonecrosis of the Jaw - pathology | Immunoglobulin Fc Fragments - pharmacology | Mice | Denosumab - pharmacology | Bisphosphonate-Associated Osteonecrosis of the Jaw - drug therapy | Diphosphonates - pharmacology | Osteoporosis | Bones | Phosphonates | Necrosis | Animal models | Zoledronic acid | Mandibles | Osteonecrosis | Acid phosphatase (tartrate-resistant) | TRANCE protein | Acid phosphatase | Bisphosphonates | Osteoprotegerin | Metastases
Journal Article
Journal Article